BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 18375250)

  • 1. Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels.
    Akinci B; Comlekci A; Yener S; Bayraktar F; Demir T; Ozcan MA; Yuksel F; Yesil S
    Arch Med Res; 2008 May; 39(4):397-401. PubMed ID: 18375250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis.
    Vural P; Degirmencioglu S; Erden S; Gelincik A
    Int Immunopharmacol; 2009 Feb; 9(2):212-5. PubMed ID: 19028605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.
    Manolova I; Gerenova J; Ivanova M
    Eur Cytokine Netw; 2013 Mar; 24(1):69-74. PubMed ID: 23614931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of hypothyroidism caused by Hashimoto's thyroiditis.
    Comtois R; Faucher L; Laflèche L
    Arch Intern Med; 1995 Jul; 155(13):1404-8. PubMed ID: 7794089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with L-thyroxine.
    Guclu F; Ozmen B; Kirmaz C; Kafesciler SO; Degirmenci PB; Taneli F; Hekimsoy Z
    Eur Cytokine Netw; 2009 Mar; 20(1):27-32. PubMed ID: 19318318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between thyroid volume, L-thyroxine therapy and hepatocyte growth factor levels among patients with euthyroid and hypothyroid goitrous and non-goitrous Hashimoto's thyroiditis versus healthy subjects.
    Kilic MK; Yesilkaya Y; Tezcan K; Cinar N; Akin S; Karakaya J; Akata D; Usman A; Gurlek A
    Endocr Res; 2016 May; 41(2):110-5. PubMed ID: 26726836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostatic effects of levothyroxine and selenomethionine in euthyroid patients with Hashimoto's thyroiditis.
    Krysiak R; Okopien B
    Thromb Haemost; 2012 Nov; 108(5):973-80. PubMed ID: 22918596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of circulating sTWEAK in the pathogenesis of Hashimoto's thyroiditis - a pilot study.
    Altay M; Ateş İ; Yılmaz FM; Topçuoğlu C; Kaplan M
    Endokrynol Pol; 2016; 67(6):562-566. PubMed ID: 26884302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive thrombocytosis accompanying subclinical hypothyroidism due to Hashimoto's thyroiditis.
    Beyan C; Kaptan K
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):649-51. PubMed ID: 23518829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High ghrelin levels in post-treatment euthyroid patients with Hashimoto's thyroiditis: a case-control preliminary study.
    Malandrino N; Miceli A; Leggio L; Mingrone G; Capristo E
    Exp Clin Endocrinol Diabetes; 2014 Oct; 122(9):540-3. PubMed ID: 24918532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of serum immunoglobulin G in Hashimoto's thyroiditis and decrease after treatment with L-thyroxine in hypothyroid patients.
    Yamauchi K; Yamada T; Sato A; Inazawa K; Aizawa T
    Intern Med; 2010; 49(4):267-71. PubMed ID: 20154430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperparathyroidism unmasked by the treatment of hypothyroidism secondary to Hashimoto's thyroiditis.
    Calandra DB; Shah K; Lawrence AM; Paloyan E
    Surgery; 1984 Dec; 96(6):1015-8. PubMed ID: 6548840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis.
    Krysiak R; Okopien B
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2206-15. PubMed ID: 21508145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural course of Hashimoto's thyroiditis in children and adolescents.
    Lee HS; Hwang JS
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):807-12. PubMed ID: 24756046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compared with classic Hashimoto's thyroiditis, chronic autoimmune serum-negative thyroiditis requires a lower substitution dose of L-thyroxine to correct hypothyroidism.
    Croce L; De Martinis L; Pinto S; Coperchini F; Dito G; Bendotti G; Pasquali D; Cappelli C; Latrofa F; Magri F; Chiovato L; Rotondi M
    J Endocrinol Invest; 2020 Nov; 43(11):1631-1636. PubMed ID: 32319047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Transforming Growth Factor-β1 Gene Polymorphism and Its Serum Levels in Hashimoto's Thyroiditis.
    Stanilova SA; Gerenova JB; Miteva LD; Manolova IM
    Curr Pharm Biotechnol; 2018; 19(7):581-589. PubMed ID: 30070177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine.
    Fiore E; Rago T; Latrofa F; Provenzale MA; Piaggi P; Delitala A; Scutari M; Basolo F; Di Coscio G; Grasso L; Pinchera A; Vitti P
    Endocr Relat Cancer; 2011 Aug; 18(4):429-37. PubMed ID: 21565972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary flow reserve after L-thyroxine therapy in Hashimoto's thyroiditis patients with subclinical and overt hypothyroidism.
    Oflaz H; Kurt R; Sen F; Onur I; Cimen AO; Elitok A; Turkmen K; Pamukcu B; Kasikcioglu E; Bugra Z; Mercanoglu F; Ozbey N
    Endocrine; 2007 Dec; 32(3):264-70. PubMed ID: 18224461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
    Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
    Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.